Who are the key players in the IV hydration therapy market?

Some of the key players in the global IV hydration therapy market include Baxter, B. Braun SE, Otsuka Pharmaceutical Co., Ltd., Grifols, S.A., Vifor Pharma Management Ltd., JW Life Science Corporation, Amanta Healthcare, NexGen Health, Core IV Therapy, LLC, Cryojuvenate UK Ltd., Drip Hydration, and REVIV.

Which segment accounted for the largest IV hydration therapy market share?

North America dominated the IV hydration therapy market with a share of 46.7% in 2025and is anticipated to maintain its dominance over the forecast period. The high share of the market in the region can be due to the unprecedented adoption of IV hydration therapy in the U.S.

What are the factors driving the intravenous hydration therapy Market?

The growth of the intravenous hydration therapy market is attributed to rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, autoimmune conditions, and cancer, the growing popularity of wellness and beauty treatments, and the increasing availability of IV hydration therapy clinics, as well as the ease of use associated with this therapy.

What is the intravenous (IV) hydration therapy Market Growth?

The global intravenous (IV) hydration therapy market is expected to grow at a compound annual growth rate of 9.2% from 2026 to 2033 to reach USD 5.66 billion by 2033.